Iomar Barrett was diagnosed with ALS in April 2024. His current focus is bringing a novel gene therapy to those with sporadic ALS via Celosia Therapeutics. He is a retired hedge fund manager, based in Monaco. He is married with two young children.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities.
Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand.
You can read more about our editorial policy here.
